Smartleaf Asset Management’s AstraZeneca AZN Stock Holding History

Smartleaf Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.02M	Sell	10,439 -3,858	-27%	-$744K	0.07%	242
2025 Q4	$2.65M	Buy	14,297 +1,923	+16%	+$337K	0.1%	178
2025 Q3	$1.83M	Buy	12,374 +4,683	+61%	+$709K	0.11%	200
2025 Q2	$1.07M	Sell	7,691 -464	-6%	-$65K	0.09%	240
2025 Q1	$1.2M	Buy	8,155 +993	+14%	+$144K	0.12%	195
2024 Q4	$939K	Buy	7,162 +2,624	+58%	+$367K	0.1%	226
2024 Q3	$704K	Buy	4,538 +1,126	+33%	+$182K	0.09%	248
2024 Q2	$533K	Buy	3,412 +928	+37%	+$140K	0.09%	238
2024 Q1	$339K	Buy	2,484 +437	+21%	+$57.9K	0.07%	263
2023 Q4	$275K	Buy	+2,047	New	+$266K	0.07%	260

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Smartleaf Asset Management's AZN Position: Q1 2026 in Review

Smartleaf Asset Management reduced its AstraZeneca (AZN) stake by 27% in Q1 2026, selling an estimated $744K and leaving 10,439 shares worth $2.02M. The position accounts for 0.07% of the portfolio, ranked #242.

Smartleaf Asset Management first reported a position in AZN in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.65M in Q4 2025. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Smartleaf Asset Management held 10,439 shares of AstraZeneca worth $2.02M as of Q1 2026.
Smartleaf Asset Management sold 3,858 AstraZeneca shares in Q1 2026, an estimated $744K.
AstraZeneca made up 0.07% of Smartleaf Asset Management's portfolio in Q1 2026, its #242 holding.
Smartleaf Asset Management first reported a position in AstraZeneca in Q4 2023 and has held it in 10 quarters since.
Smartleaf Asset Management's AstraZeneca position peaked at $2.65M in Q4 2025.
1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.